New! Sign up for our free email newsletter.
Science News
from research organizations

Early Exposure To Synthetic Estrogen Puts 'DES Daughters' At Higher Risk For Breast Cancer

Date:
August 7, 2006
Source:
American Association for Cancer Research
Summary:
So-called "DES daughters," born to mothers who used the anti-miscarriage drug, diethylstilbestrol during pregnancy, are at a substantially greater risk of developing breast cancer compared to women who were not exposed to the drug in utero.
Share:
FULL STORY

So-called "DES daughters," born to mothers who used the anti-miscarriage drug diethylstilbestrol during pregnancy, are at a substantially greater risk of developing breast cancer compared to women who were not exposed to the drug in utero.

Story Source:

Materials provided by American Association for Cancer Research. Note: Content may be edited for style and length.

Cite This Page:

American Association for Cancer Research. "Early Exposure To Synthetic Estrogen Puts 'DES Daughters' At Higher Risk For Breast Cancer." ScienceDaily. ScienceDaily, 7 August 2006. <www.sciencedaily.com/releases/2006/08/060807121533.htm>.
American Association for Cancer Research. (2006, August 7). Early Exposure To Synthetic Estrogen Puts 'DES Daughters' At Higher Risk For Breast Cancer. ScienceDaily. Retrieved October 10, 2025 from www.sciencedaily.com/releases/2006/08/060807121533.htm
American Association for Cancer Research. "Early Exposure To Synthetic Estrogen Puts 'DES Daughters' At Higher Risk For Breast Cancer." ScienceDaily. www.sciencedaily.com/releases/2006/08/060807121533.htm (accessed October 10, 2025).

Explore More

from ScienceDaily
RELATED STORIES

Breaking

this hour
this week

Strange & Offbeat